Drug against central nervous system inflammation
AssigneesFujino Brain Research, Ltd., Umeda Jimusho Ltd., Marudai Food Co., Ltd.
InventorsShirou Mawatari, Takehiko Fujino, Masataka Ifuku, Masaaki Sugiyama, Hidetaka Fuchu
Life of this patent
Estimating the term…
Abstract
An objective of the present invention is to provide a novel method with an effect of alleviating central nervous system inflammation. The present invention provides a drug against central nervous system inflammation containing a plasmalogen. More preferably, the present invention provides a drug against central nervous system inflammation containing a plasmalogen extracted from a biological tissue (preferably an avian tissue) that mainly contains an ethanolamine plasmalogen and a choline plasmalogen.
Claims8
A drug against central nervous system inflammation containing a plasmalogen.
Dependencies are inferred from the claim text.